Overview
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 7, 2018 | Top tech startup news stories you need to know this Friday, September 7 | Good morning! Here are some of the top tech startup news stories for today, Friday, September 7. Tesla stock drops 9 percent after Elon Musk smokes weed on a podcast and top executives resign. Shares of Tesla tanked about 9 percent lower F... |
| Sep 26, 2016 | Will digital health’s impact in pharma mean that size will matter less? | The discussion about pharmaceutical companies’ adoption of digital health tends to revolve around what Big Pharma businesses are doing. But at the annual Health 2.0 Fall conference this week, BTG Digital Health Innovation Director Amanda Go... |
| Jan 18, 2012 | Drug to combat kidney failure from chemotherapy gets FDA approval | “Prolonged exposure to high levels of methotrexate can result in kidney and liver damage, severe mouth sores, damage to the lining of the intestine, skin rashes and death due to low blood counts,” Dr. Richard Pazdur, director of the office ... |
| Apr 20, 2009 | Attitudes are contagious... are yours worth catching? | Attitudes are contagious... are yours worth catching? 20-04-2009 Attitudes make a real difference. Find out why attitude is important to an inspiring and successful leader and how to spot the right ones. What is it about some people? Anythi... |
| Jan 18, 2008 | Life sciences briefing: Friday, Jan. 18, 2007 | TODAY’S HEADLINES: Ulthera receives $23M for cosmetic ultrasound devices (release) Senexis raises £2.9M for Alzheimer’s drugs (PDF release) Elixir Pharma postpones IPO (IPO Home) Cancer Therapeutics names Randall Riggs as CEO (release) Ulth... |
| Sep 20, 2005 | BTG plc reports progress on Campath(R) trials | BTG plc reports progress on Campath(R) trials 20-09-2005 BTG plc, the medical innovations company, today reports that Genzyme Corporation, BTG's licensee for Campath(R), and Schering AG have announced interim results of the Phase II tr... |
| Dec 9, 2004 | BTG plc: Business update | BTG plc: Business update 09-12-2004 BTG plc (LSE: BGC), the IP and technology commercialisation company, has announced action to increase focus in its business activities and reduce its cost base as part of a business review announced on 11... |
| Apr 28, 2004 | Ignios Secures $3.8 Million First Round Funding from BTG and Alice Lab | Investment supports next phase of product development; innovative on-chip solution to burgeoning problem of system management in multi-core devices Oxford, UK, 28th April 2004. Ignios Ltd., a new entrant in the embedded system-on-chip marke... |
| Dec 1, 2003 | BTG plc announces interim results | BTG plc announces interim results 01-12-2003 BTG plc (LSE: BGC), the global technology commercialisation company, today announces its Interim Results for the six months ended 30 September 2003. Financial highlights include: Total revenues i... |
Reviews 0
FAQ about BTG
When was BTG founded?
BTG was founded in 1948.
What has the press written about BTG?
Parsers VC has collected 12 articles mentioning BTG, among them “Top tech startup news stories you need to know this Friday, September 7” (Sep 7, 2018) and “Will digital health’s impact in pharma mean that size will matter less?” (Sep 26, 2016).
Is BTG still active?
Yes, BTG is active; its latest activity on Parsers VC dates from Nov 18, 2024.